Last reviewed: July 1, 2026
Last updated: July 1, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Many patients assume that GLP-1 receptor agonists like semaglutide are dosed strictly by body weight, similar to how insulin or certain chemotherapy drugs are calculated. In reality, semaglutide follows a standardized titration protocol that increases over four weeks, with adjustments based on individual tolerance and clinical response rather than pounds on a scale.
How Semaglutide Dosing Actually Works
Semaglutide uses a fixed-dose escalation schedule, not a weight-based calculation. The standard protocol begins at 0.25 mg once weekly for four weeks, then increases to 0.5 mg weekly for the next four weeks. This measured approach allows your body to adapt to the medication while your prescriber observes how well you're tolerating it. Each step in this titration sequence is the same regardless of whether you weigh 180 pounds or 280 pounds.
Once you reach the 0.5 mg maintenance dose, your provider can continue at that level or escalate further based on your personal response and goals. Some patients find optimal results at 0.5 mg weekly, while others benefit from advancing to 1 mg or 1.7 mg doses. Your dose may need to go up. Your price won't—PlexusDx's compounded semaglutide injection pricing remains flat at the starting rate of $149 per month, no matter which maintenance dose you eventually use.
Factors That Actually Drive Semaglutide Dose Adjustments
Your clinical response determines whether your dose will increase, not your body weight. Prescribers monitor appetite suppression, blood sugar control, weight loss progress, and nausea severity to decide if you need a higher dose. Someone who experiences strong appetite reduction and steady weight loss at 0.5 mg may never need escalation, while a person at a similar starting weight might advance to 1 mg for better glycemic control. This personalized approach reflects real-world physiology rather than a one-size-fits-all metric.
Gastrointestinal tolerance also shapes dosing decisions. If you experience significant nausea or vomiting at a given dose, your provider may keep you at a lower level longer or adjust frequency rather than continuing to increase. Kidney function, liver health, and concurrent medications can also influence how quickly or far your dose escalates. PlexusDx's approach emphasizes gradual, symptom-guided titration to maximize safety and long-term adherence.
Why Weight Doesn't Determine Your Semaglutide Dose
Semaglutide's mechanism focuses on slowing gastric emptying and signaling fullness to your brain—effects that occur at specific drug concentrations in your bloodstream, not proportional to your body weight. Unlike insulin, which must account for total body glucose handling capacity, semaglutide's GLP-1 receptor effects are triggered at consistent threshold doses. Clinical trials that established semaglutide's safety used fixed-dose escalation, not weight-adjusted protocols, demonstrating efficacy across diverse body sizes.
Individual genetic variation in GLP-1 receptor function explains why two people of identical weight may have different optimal doses. PlexusDx's Precision Peptide Genetic Test identifies variants in your GLP1R gene (rs6923761) and other metabolic pathways that predict how sensitively your body will respond to semaglutide. This genetic insight, combined with clinical observation, enables truly personalized dosing that goes far beyond what a weight calculation could offer.
Compounded Semaglutide vs. Brand Ozempic: Dosing Similarities
PlexusDx's compounded semaglutide from licensed 503A pharmacies follows the same titration logic as brand Ozempic. The active pharmaceutical ingredient is identical, so your body's response and your provider's dosing decisions will be guided by the same clinical principles. The key difference is cost and access: compounded semaglutide starts at $149 per month with no insurance required and works with HSA/FSA accounts, removing financial barriers that brand-name therapy often imposes.
Both formulations are dosed by body weight and individual response, not by weight alone. Whether you choose compounded semaglutide from PlexusDx or a brand alternative, your prescriber will track your tolerance, appetite, and weight-loss outcomes to guide any dose increases. PlexusDx's flat monthly pricing means you can pursue optimal dosing without watching your copay climb with each tier adjustment.
Personalized Dosing Through Genetic Testing and Titration
PlexusDx combines clinical titration with genetic insight to refine dosing decisions. The Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 metabolic pathways and 150+ genetic insights, including variants that predict GLP-1 sensitivity, appetite regulation, and weight-loss response. Knowing your genetic profile helps your provider anticipate whether you're likely to respond robustly at lower doses or may benefit from faster titration to higher maintenance levels.
This personalized approach reduces guesswork and trial-and-error dose adjustments. Patients with genetic variants suggesting high GLP-1 receptor sensitivity might achieve excellent results at 0.5 mg, while others with reduced sensitivity may advance more aggressively toward 1.7 mg doses. PlexusDx's genetic testing empowers your prescriber to skip ineffective dose ranges and move toward your optimal therapeutic level faster, saving time and improving outcomes.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is semaglutide dosage calculated based on how much I weigh?
No. Semaglutide uses a standardized titration schedule starting at 0.25 mg weekly, increasing every four weeks regardless of body weight. Your dose adjustments depend on how well you tolerate the medication and your clinical response, not on pounds. PlexusDx's compounded semaglutide injection begins at $149 per month and maintains that flat price as your dose increases.
Will a heavier person need a higher semaglutide dose than a lighter person?
Not necessarily. Clinical response and tolerance guide dose escalation, not body weight. Two patients of different weights may both reach optimal results at 1 mg weekly, while others may need 1.7 mg or be satisfied at 0.5 mg. PlexusDx's personalized approach considers your individual genetic makeup and clinical progress rather than applying weight-based formulas.
What does 'your dose may go up, your price won't' mean?
PlexusDx charges a flat monthly rate for compounded semaglutide ($149/mo) regardless of which maintenance dose you ultimately use. If your prescriber increases your semaglutide from 0.5 mg to 1 mg or higher, your monthly cost stays the same. This pricing structure removes the financial deterrent to pursuing optimal dosing.
How long does it take to reach my maintenance semaglutide dose?
The standard titration takes at least eight weeks to reach 0.5 mg maintenance. Further increases to 1 mg or 1.7 mg typically occur in four-week intervals based on tolerance and response. Your prescriber may adjust this timeline based on side effects or clinical needs, but slow, gradual escalation is the evidence-based standard for safety and tolerability.
Can the Precision Peptide Genetic Test predict if I need a higher semaglutide dose?
Yes. PlexusDx's Precision Peptide Genetic Test examines variants in GLP1R (rs6923761), GIPR, FTO, MC4R, and 10 other pathways affecting peptide sensitivity and weight regulation. Genetic insights help your provider anticipate whether you'll respond robustly at standard doses or may benefit from earlier or more aggressive titration, enabling faster optimization.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Wegovy Helps You Lose Weight: A Comprehensive Exploration
Navigating the Path to Wegovy: Understanding How Long It Takes to Get Approved